Camilla Lundgren Pedersen - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

CHEST Pulmonary|August 4, 2026

Cardiopulmonary Exercise Testing in Patients With Long COVID: Evaluating Functional Capacity and Exercise LimitationsLotte Sørensen, Camilla Lundgren Pedersen, Mads Jønsson Andersen, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 6, 2022

Change in exercise capacity measured by Cardio-pulmonary Exercise Testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with Lumacaftor/Ivacaftor and Tezacaftor/IvacaftorUlla Kildall Rysgaard, Camilla Lundgren Pedersen, Janne Hastrup Jensen, et al.

Pediatric Pulmonology|September 8, 2020

Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatmentLinnea Chika Kristensen Ejiofor, Inger Hee Mabuza Mathiesen, Søren Jensen-Fangel, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

CHEST Pulmonary|August 4, 2026

Cardiopulmonary Exercise Testing in Patients With Long COVID: Evaluating Functional Capacity and Exercise LimitationsLotte Sørensen, Camilla Lundgren Pedersen, Mads Jønsson Andersen, et al.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 6, 2022

Change in exercise capacity measured by Cardio-pulmonary Exercise Testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with Lumacaftor/Ivacaftor and Tezacaftor/IvacaftorUlla Kildall Rysgaard, Camilla Lundgren Pedersen, Janne Hastrup Jensen, et al.

Pediatric Pulmonology|September 8, 2020

Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatmentLinnea Chika Kristensen Ejiofor, Inger Hee Mabuza Mathiesen, Søren Jensen-Fangel, et al.

Pageof 1